Gilead Sciences Inc (GILD)

1,731.00 -19.00 (-1.09%)
Closed MXN Disclaimer

Gilead Sciences Inc Company Profile

Industry
Biotechnology
Sector
Healthcare
Employees
14400
Equity Type
ORD
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of coronavirus disease 2019; and Epclusa, Harvoni, Vosevi, Vemlidy, and Viread for the treatment of liver diseases. It also offers Yescarta, Tecartus, Trodelvy, and Zydelig products for the treatment of hematology, oncology, and cell therapy patients. In addition, the company provides Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; Ranexa, an oral formulation for the treatment of chronic angina; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. Gilead Sciences, Inc. has collaboration agreements with Arcus Biosciences, Inc.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Tango Therapeutics, Inc.; Jounce Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Gadeta B.V.; Bristol-Myers Squibb Company; Dragonfly Therapeutics, Inc.; and Merck & Co, Inc. The company was incorporated in 1987 and is headquartered in Foster City, California.
Contact Information
Address
Foster City,94404 United States
Phone
650 574 3000
Fax
650 522 5853
Top Executives
Name
Age
Since
Title
Eugene R. Schiff 0 0000 Member of the Scientific Advisory Board
Jacqueline K. Barton 68 1989 Independent Director
Paul E. Klotman 0 0000 Member of the Scientific Advisory Board
John W. Mellors 83 0000 Member of the Scientific Advisory Board
Francis V. Chisari 0 0000 Member of the Scientific Advisory Board
Sandra J. Horning 72 2020 Independent Director
Mark C. Genovese 0 0000 Member of Scientific Advisory Board
Daniel P. O'Day 57 2019 Chairman & CEO
Harish M. Manwani 68 2018 Independent Director
Malcolm MacCoss 73 0000 Member of Scientific Advisory Board
Nezam H. Afdhal 64 0000 Member of Scientific Advisory Board
Robert A. Harrington 0 0000 Member of the Scientific Advisory Board
Kevin E. Lofton 66 2009 Lead Independent Director
Paul Berg 94 1998 Member of Scientific Advisory Board
Kelly A. Kramer 53 2016 Independent Director
Eric J. Topol 67 0000 Member of Scientific Advisory Board
Robert T. Schooley 0 0000 Member of the Scientific Advisory Board
Kenneth C. Anderson 70 0000 Member of the Scientific Advisory Board
Brian J. Druker 66 0000 Member of the Scientific Advisory Board
Joel R. Huff 0 0000 Chairperson of Scientific Advisory Board
Javier J. Rodriguez 50 2020 Independent Director
Jeffrey A. Bluestone 68 2020 Independent Director
Anthony Welters 66 2020 Independent Director
Clear All
0Selected
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.